These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 35443459)

  • 21. Correlation between hs-CRP, IL-6, IL-10, ET-1, and Chronic Obstructive Pulmonary Disease Combined with Pulmonary Hypertension.
    Yang D; Wang L; Jiang P; Kang R; Xie Y
    J Healthc Eng; 2022; 2022():3247807. PubMed ID: 35186226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COPD assessment test score and serum C-reactive protein levels in stable COPD patients.
    Kang HK; Kim K; Lee H; Jeong BH; Koh WJ; Park HY
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3137-3143. PubMed ID: 27994452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients.
    Cheng SL; Lin CH; Wang CC; Chan MC; Hsu JY; Hang LW; Perng DW; Yu CJ; Wang HC;
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):429-435. PubMed ID: 30150099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.
    Rhee CK; Kim JW; Hwang YI; Lee JH; Jung KS; Lee MG; Yoo KH; Lee SH; Shin KC; Yoon HK
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1623-31. PubMed ID: 26316736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Echocardiographic Evaluation of the Relationship Between inflammatory factors (IL6, TNFα, hs-CRP) and Secondary Pulmonary Hypertension in patients with COPD. A Cross sectional study.
    Ansarin K; Rashidi F; Namdar H; Ghaffari M; Sharifi A
    Pneumologia; 2015; 64(3):31-5. PubMed ID: 26738368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.
    Garcia-Rio F; Miravitlles M; Soriano JB; Muñoz L; Duran-Tauleria E; Sánchez G; Sobradillo V; Ancochea J;
    Respir Res; 2010 May; 11(1):63. PubMed ID: 20500811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of Health-Related Quality of Life (HRQOL) in Patients With Chronic Obstructive Pulmonary Disease using the COPD Assessment Test (CAT).
    Akor AA; Bamidele A; Erhabor GE
    West Afr J Med; 2020; 37(3):275-280. PubMed ID: 32476122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.
    Kolsum U; Roy K; Starkey C; Borrill Z; Truman N; Vestbo J; Singh D
    Int J Chron Obstruct Pulmon Dis; 2009; 4():149-56. PubMed ID: 19436686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.
    Samy N; Hashim M; Sayed M; Said M
    Dis Markers; 2009; 26(4):163-70. PubMed ID: 19729797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subjective sleep quality is associated with disease status in COPD patients. The cross-sectional Greek UNLOCK study.
    Ierodiakonou D; Bouloukaki I; Kampouraki M; Papadokostakis P; Poulorinakis I; Lampraki I; Athanasiou P; Schiza S; Tsiligianni I;
    Sleep Breath; 2020 Dec; 24(4):1599-1605. PubMed ID: 32103395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The acute inflammatory response after trauma is heightened by frailty: A prospective evaluation of inflammatory and endocrine system alterations in frailty.
    Palmer J; Pandit V; Zeeshan M; Kulvatunyou N; Hamidi M; Hanna K; Fain M; Nikolich-Zugich J; Zakaria ER; Joseph B
    J Trauma Acute Care Surg; 2019 Jul; 87(1):54-60. PubMed ID: 30768559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of the CAT in the therapy assessment of COPD exacerbations in China.
    Tu YH; Zhang Y; Fei GH
    BMC Pulm Med; 2014 Mar; 14():42. PubMed ID: 24618290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation in Assignment of the COPD Patients into a GOLD Group According to Symptoms Severity.
    Moya-Álvarez V; Quevedo-Marín JL; Ji Z; Navarro-Jiménez C; Jiménez-García R; López-de-Andrés A; Pérez-Trullén A; de Miguel-Díez J
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1987-1995. PubMed ID: 32848383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional capacity and inflammatory biomarkers as predictors for right atrial volume index in COPD patients.
    Khedr L; Khedr NF; Werida RH
    Int J Cardiovasc Imaging; 2023 Aug; 39(8):1493-1504. PubMed ID: 37217717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified Medical Research Council Dyspnea Scale in GOLD Classification Better Reflects Physical Activities of Daily Living.
    Munari AB; Gulart AA; Dos Santos K; Venâncio RS; Karloh M; Mayer AF
    Respir Care; 2018 Jan; 63(1):77-85. PubMed ID: 28874609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of acupuncture on nutritional state of patients with stable chronic obstructive pulmonary disease (COPD): re-analysis of COPD acupuncture trial, a randomized controlled trial.
    Suzuki M; Muro S; Fukui M; Ishizaki N; Sato S; Shiota T; Endo K; Suzuki T; Mitsuma T; Mishima M; Hirai T
    BMC Complement Altern Med; 2018 Oct; 18(1):287. PubMed ID: 30355325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surfactant protein D, soluble intercellular adhesion molecule-1 and high-sensitivity C-reactive protein as biomarkers of chronic obstructive pulmonary disease.
    El-Deek SE; Makhlouf HA; Saleem TH; Mandour MA; Mohamed NA
    Med Princ Pract; 2013; 22(5):469-74. PubMed ID: 23860258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the Chinese herb formula Yufeining on stable chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial.
    Hong M; Hong C; Chen H; Ke G; Huang J; Huang X; Liu Y; Li F; Li C
    Medicine (Baltimore); 2018 Sep; 97(39):e12461. PubMed ID: 30278529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Systemic inflammation in patients with chronic obstructive pulmonary disease and obesity].
    Ovsyannikov ES; Avdeev SN; Budnevsky AV
    Ter Arkh; 2020 Apr; 92(3):13-18. PubMed ID: 32598787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification.
    Jones PW; Adamek L; Nadeau G; Banik N
    Eur Respir J; 2013 Sep; 42(3):647-54. PubMed ID: 23258783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.